Literature DB >> 18795373

Predictors of mortality in patients with stable COPD.

Cristóbal Esteban1, José M Quintana, Myriam Aburto, Javier Moraza, Mikel Egurrola, Pedro Pablo España, Julio Pérez-Izquierdo, Alberto Capelastegui.   

Abstract

OBJECTIVES: To determine which easily available clinical factors are associated with mortality in patients with stable COPD and if health-related quality of life (HRQoL) provides additional information.
DESIGN: Five-year prospective cohort study.
SETTING: Five outpatient clinics of a teaching hospital. PARTICIPANTS: Six hundred stable COPD patients recruited consecutively. MEASUREMENTS: The variables were age, FEV(1%), dyspnea, previous hospital admissions and emergency department visits for COPD, pack-years of smoking, comorbidities, body mass index, and HRQoL measured by Saint George's Respiratory Questionnaire (SGRQ), Chronic Respiratory Questionnaire (CRQ), and Short-Form 36 (SF-36). Logistic and Cox regression models were used to assess the influence of these variables on mortality and survival.
RESULTS: FEV(1%)(OR: 0.62, 95% CI 0.5 to 0.75), dyspnea (OR 1.92, 95% CI 1.2 to 3), age (OR 2.41, 95% CI 1.6 to 3.6), previous hospitalization due to COPD exacerbations (OR 1.53, 1.2 to 2) and lifetime pack-years (OR 1.15, 95% CI 1.1 to 1.2) were independently related to respiratory mortality. Similarly, these factors were independently related to all-cause mortality with dyspnea having the strongest association (OR 1.54, 95% CI 1.1 to 2.2). HRQoL was an independent predictor of respiratory and all-cause mortality only when dyspnea was excluded from the models, except scores on the SGRQ were associated with all-cause mortality with dyspnea in the model.
CONCLUSIONS: Among patients with stable COPD, FEV(1%) was the main predictor of respiratory mortality and dyspnea of all-cause mortality. In general, HRQoL was not related to mortality when dyspnea was taken into account, and CRQ and SGRQ behaved in similar ways regarding mortality.

Entities:  

Mesh:

Year:  2008        PMID: 18795373      PMCID: PMC2585660          DOI: 10.1007/s11606-008-0783-x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  28 in total

1.  Continuous measurement of breathlessness during exercise: validity, reliability, and responsiveness.

Authors:  D A Mahler; R Mejia-Alfaro; J Ward; J C Baird
Journal:  J Appl Physiol (1985)       Date:  2001-06

2.  A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD.

Authors:  T Hajiro; K Nishimura; M Tsukino; A Ikeda; T Oga; T Izumi
Journal:  Chest       Date:  1999-12       Impact factor: 9.410

3.  Mortality after hospitalization for COPD.

Authors:  Pedro Almagro; Esther Calbo; Anna Ochoa de Echagüen; Bienvenido Barreiro; Salvador Quintana; José L Heredia; Javier Garau
Journal:  Chest       Date:  2002-05       Impact factor: 9.410

4.  Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD.

Authors:  Koichi Nishimura; Takateru Izumi; Mitsuhiro Tsukino; Toru Oga
Journal:  Chest       Date:  2002-05       Impact factor: 9.410

5.  Prognostic value of nutritional status in chronic obstructive pulmonary disease.

Authors:  C Landbo; E Prescott; P Lange; J Vestbo; T P Almdal
Journal:  Am J Respir Crit Care Med       Date:  1999-12       Impact factor: 21.405

Review 6.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

7.  Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease.

Authors:  Antònia Domingo-Salvany; Rosa Lamarca; Montserrat Ferrer; Judith Garcia-Aymerich; Jordi Alonso; Miquel Félez; Ahmad Khalaf; Ramon M Marrades; Eduard Monsó; Joan Serra-Batlles; Josep M Antó
Journal:  Am J Respir Crit Care Med       Date:  2002-09-01       Impact factor: 21.405

8.  Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status.

Authors:  Toru Oga; Koichi Nishimura; Mitsuhiro Tsukino; Susumu Sato; Takashi Hajiro
Journal:  Am J Respir Crit Care Med       Date:  2002-11-21       Impact factor: 21.405

9.  Health status measured with the CRQ does not predict mortality in COPD.

Authors:  T Oga; K Nishimura; M Tsukino; S Sato; T Hajiro; A Ikeda; M Mishima
Journal:  Eur Respir J       Date:  2002-11       Impact factor: 16.671

10.  Hospitalizations and mortality in the Lung Health Study.

Authors:  Nicholas R Anthonisen; John E Connett; Paul L Enright; Jure Manfreda
Journal:  Am J Respir Crit Care Med       Date:  2002-08-01       Impact factor: 21.405

View more
  22 in total

1.  Factors associated with mortality in patients with exacerbation of chronic obstructive pulmonary disease hospitalized in General Medicine departments.

Authors:  Bernardino Roca; Pedro Almagro; Francisco López; Francisco J Cabrera; Lorena Montero; David Morchón; Jesús Díez; Fernando de la Iglesia; Mario Fernández; Jesús Castiella; Elena Zubillaga; Jesús Recio; Joan B Soriano
Journal:  Intern Emerg Med       Date:  2010-10-01       Impact factor: 3.397

Review 2.  Pharmacists performing quality spirometry testing: an evidence based review.

Authors:  Michael J Cawley; William J Warning
Journal:  Int J Clin Pharm       Date:  2015-07-07

3.  A decision tree to assess short-term mortality after an emergency department visit for an exacerbation of COPD: a cohort study.

Authors:  Cristóbal Esteban; Inmaculada Arostegui; Susana Garcia-Gutierrez; Nerea Gonzalez; Iratxe Lafuente; Marisa Bare; Nerea Fernandez de Larrea; Francisco Rivas; José M Quintana
Journal:  Respir Res       Date:  2015-12-22

4.  Dyspnea: a strong independent factor for long-term mortality in the elderly.

Authors:  M Berraho; C Nejjari; K El Rhazi; J F Tessier; J F Dartigues; P Barberger-Gateau; C Raherison
Journal:  J Nutr Health Aging       Date:  2013       Impact factor: 4.075

5.  The Dyspnoea, Obstruction, Smoking, Exacerbation (DOSE) index is predictive of mortality in COPD.

Authors:  Josefin Sundh; Christer Janson; Karin Lisspers; Björn Ställberg; Scott Montgomery
Journal:  Prim Care Respir J       Date:  2012-09

6.  Symptom cluster, healthcare use and mortality in patients with severe chronic obstructive pulmonary disease.

Authors:  Soo Kyung Park; Janet L Larson
Journal:  J Clin Nurs       Date:  2014-01-27       Impact factor: 3.036

7.  BODE-Index vs HADO-score in chronic obstructive pulmonary disease: Which one to use in general practice?

Authors:  Cristóbal Esteban; José M Quintana; Javier Moraza; Myriam Aburto; Urko Aguirre; José I Aguirregomoscorta; Susana Aizpiri; Luis V Basualdo; Alberto Capelastegui
Journal:  BMC Med       Date:  2010-05-24       Impact factor: 8.775

8.  Predictors of one-year mortality after hospitalization for an exacerbation of COPD.

Authors:  Cristóbal Esteban; Ady Castro-Acosta; Carlos Jose Alvarez-Martínez; Alberto Capelastegui; José Luis López-Campos; Francisco Pozo-Rodriguez
Journal:  BMC Pulm Med       Date:  2018-01-25       Impact factor: 3.317

9.  Health-related Quality of Life and Survival in Pulmonary Arterial Hypertension.

Authors:  Stephen C Mathai; Tomeka Suber; Rubina M Khair; Todd M Kolb; Rachel L Damico; Paul M Hassoun
Journal:  Ann Am Thorac Soc       Date:  2016-01

10.  The Association between Continuity of Care and All-Cause Mortality in Patients with Newly Diagnosed Obstructive Pulmonary Disease: A Population-Based Retrospective Cohort Study, 2005-2012.

Authors:  Kyoung Hee Cho; Young Sam Kim; Chung Mo Nam; Tae Hyun Kim; Sun Jung Kim; Kyu-Tae Han; Eun-Cheol Park
Journal:  PLoS One       Date:  2015-11-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.